The most widely studied polymorphisms of the ABCB1 gene are rs1128503 (c.1236C>T), rs2032582 (c.2677G>T/A), and rs1045642 (c.3435C>T). Although variation in ABCB1 allele frequencies among Mexican Mestizos (admixed) from different regions has been observed, Mexican Amerindians have been poorly studied. We aimed to describe the genetic variability of these three ABCB1 polymorphisms in a total sample of 273 Mexican volunteers that included Mestizos from the state of Yucatán, and Amerindians from seven populations (Tarahumara, Mayo, Huichol, Purépecha, Nahua, Tojolabal, and Maya). Genotypes were determined by means of Taq Man probes (qPCR). Genotype distribution was in Hardy–Weinberg equilibrium for all three ABCB1polymorphisms in the eight Mexican populations analyzed. For c.1236C>T and c.3435C>T, the heterozygous C/T was the most frequent genotype in the majority of the studied Mexican populations (range 30.8–65.4%), while heterozygous G/T was the most common genotype for c.2677G>T/A (range 25.9–51.2%), mainly followed by G/G (range 3.2–47.1%) and T/T (range 7.0–35.5%). 12 haplotypes were estimated from the three ABCB1 polymorphisms analyzed, with TTT the most frequent haplotype (mean, 37.0%). Genetic differentiation was demonstrated among the studied Mexican populations (Fst p value < 0.0001), which could imply a diverse drug response or a risk for adverse drug reactions to ABCB1 substrates. Although differences among Amerindians are probably due to genetic drift effects, for Mestizos this could imply variation in admixture composition. In conclusion, interpopulation variability in the observed frequencies of ABCB1 polymorphisms among Mexican Mestizos and Amerindians allow predicting diverse drug responses to ABCB1 substrates in these populations.
ABCB1Polymorphism Mexican population Mestizos Amerindians Pharmacogenetics
This is a preview of subscription content, log in to check access.
The authors are grateful for the generous participation of indigenous volunteers in this study. We also thank CONACYT-México (Grant #167261) for financial support.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
Hodges LM, Markova SM, Chinn LW, Gow JM, Kroetz DL, Klein TE, Altman RB (2011) Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics 21(3):152–161CrossRefGoogle Scholar
Chen Z, Shi T, Zhang L et al (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370(1):153–164CrossRefGoogle Scholar
Dutheil F, Jacob A, Dauchy S, Beaune P, Scherrmann JM, Declèves X, Loriot MA (2010) ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol 6(10):1161–1174. https://doi.org/10.1517/17425255.2010.510832CrossRefPubMedGoogle Scholar
Elali A, Rivest S (2013) The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer’s disease. Front Physiol 4:45CrossRefGoogle Scholar
Zhang YT, Yang LP, Shao H, Li KX, Sun CH, Shi LW (2008) ABCB1 polymorphisms may have a minor effect on cyclosporine blood concentrations in myasthenia gravis patients. Brit J Clin Pharmacol 66:240–246CrossRefGoogle Scholar
Kim RB, Leake BF, Choo EF et al (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70(2):189–199CrossRefGoogle Scholar
Rubi-Castellanos R, Martínez-Cortés G, Muñoz-Valle JF, González-Martín A, Cerda-Flores RM, Anaya-Palafox M, Rangel-Villalobos H (2009) Pre-Hispanic mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am J Phys Anthropol 139(3):284–294. https://doi.org/10.1002/ajpa.20980CrossRefPubMedGoogle Scholar
Rangel-Villalobos H, Martínez-Sevilla VM, Martínez-Cortés G, Aguilar-Velázquez JA, Sosa-Macías M, Rubi-Castellanos R, González-Martín A (2016) Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: evidence from forensic STR Loci. Am J Phys Anthropol 160(2):298–316. https://doi.org/10.1002/ajpa.22969CrossRefPubMedGoogle Scholar
Vargas-Alarcón G, Ramírez-Bello J, de la Peña A et al (2014) Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population. Mol Biol Rep 19(10):7023–7029.CrossRefGoogle Scholar
Rodríguez-Castillo JA, Arce-Mendoza AY, Quintanilla-Siller A, Rendon A, Salinas-Carmona MC, Rosas-Taraco AG (2015) Possible association of rare polymorphism in the ABCB1 gene with rifampin and ethambutol drug-resistant tuberculosis. Tuberculosis (Edinb) 95(5):532–537. https://doi.org/10.1016/j.tube.2015.04.004CrossRefGoogle Scholar
Marsh S, King CR, Van Booven DJ, Revollo JY, Gilman RH, McLeod HL (2015) Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics 16(5):441–448CrossRefGoogle Scholar
Acuña-Alonzo V, Flores-Dorantes T, Kruit JK et al (2010) A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. Hum Mol Genet 19:2877–2885CrossRefGoogle Scholar
Williams AL, Jacobs SB, Moreno-Macías H et al (2014) Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506:97–101CrossRefGoogle Scholar
Peakall R, Smouse PE (2012) GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics 28(19):2537–2539CrossRefGoogle Scholar
Excoffier L, Laval G, Schneider S (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50CrossRefGoogle Scholar
Dudarewicz M, Barańska M, Rychlik-Sych M et al (2012) C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population. Pharmacol Rep 64(2):343–350CrossRefGoogle Scholar
Ameyaw MM, Regateiro F, Li T et al (2001) MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11(3):217–221CrossRefGoogle Scholar